These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33315491)

  • 1. By Releasing the Brakes With Immunotherapy, Are We Accelerating Atherosclerosis?
    Kondapalli L; Bottinor W; Lenneman C
    Circulation; 2020 Dec; 142(24):2312-2315. PubMed ID: 33315491
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy for Atherosclerosis-Novel Concepts.
    Steffens S; Weber C
    Thromb Haemost; 2019 Apr; 119(4):515-516. PubMed ID: 30887489
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-inflammatory and immune modulation therapy against atherosclerosis].
    Yamashita T; Hirata K
    Nihon Rinsho; 2011 Jan; 69(1):168-72. PubMed ID: 21226279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunotherapies targeting the PD-1 signaling pathway.
    Iwai Y; Hamanishi J; Chamoto K; Honjo T
    J Biomed Sci; 2017 Apr; 24(1):26. PubMed ID: 28376884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for cardiovascular disease.
    Lutgens E; Atzler D; Döring Y; Duchene J; Steffens S; Weber C
    Eur Heart J; 2019 Dec; 40(48):3937-3946. PubMed ID: 31121017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice.
    Hermansson A; Johansson DK; Ketelhuth DF; Andersson J; Zhou X; Hansson GK
    Circulation; 2011 Mar; 123(10):1083-91. PubMed ID: 21357823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells as a new therapeutic target for atherosclerosis.
    Ou HX; Guo BB; Liu Q; Li YK; Yang Z; Feng WJ; Mo ZC
    Acta Pharmacol Sin; 2018 Aug; 39(8):1249-1258. PubMed ID: 29323337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental immunotherapeutic approaches for atherosclerosis.
    Amir S; Binder CJ
    Clin Immunol; 2010 Jan; 134(1):66-79. PubMed ID: 19666239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active and passive immunization for atherosclerosis.
    Chyu KY; Nilsson J; Shah PK
    Curr Opin Mol Ther; 2007 Apr; 9(2):176-82. PubMed ID: 17458172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Releasing the Brakes on Cancer Immunotherapy.
    Ribas A
    N Engl J Med; 2015 Oct; 373(16):1490-2. PubMed ID: 26348216
    [No Abstract]   [Full Text] [Related]  

  • 11. CD8
    Schäfer S; Zernecke A
    Cells; 2020 Dec; 10(1):. PubMed ID: 33383733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T-cell immunity in atherosclerosis.
    Mallat Z; Ait-Oufella H; Tedgui A
    Trends Cardiovasc Med; 2007 May; 17(4):113-8. PubMed ID: 17482092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated mechanisms in atherosclerosis: prevention and treatment of clinical manifestations.
    Niessner A; Goronzy JJ; Weyand CM
    Curr Pharm Des; 2007; 13(36):3701-10. PubMed ID: 18220809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities.
    Khambhati J; Engels M; Allard-Ratick M; Sandesara PB; Quyyumi AA; Sperling L
    Atherosclerosis; 2018 Sep; 276():1-9. PubMed ID: 30006321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating atherosclerosis with regulatory T cells.
    Foks AC; Lichtman AH; Kuiper J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):280-7. PubMed ID: 25414253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD31 as a Therapeutic Target in Atherosclerosis.
    Caligiuri G
    Circ Res; 2020 Apr; 126(9):1178-1189. PubMed ID: 32324506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of innate and adaptive immune responses on atherosclerosis.
    Witztum JL; Lichtman AH
    Annu Rev Pathol; 2014; 9():73-102. PubMed ID: 23937439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
    Nilsson J; Wigren M; Shah PK
    Trends Cardiovasc Med; 2009 Nov; 19(8):272-6. PubMed ID: 20447570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Releasing the brakes on antitumor immune response.
    Pardoll D
    Science; 1996 Mar; 271(5256):1691. PubMed ID: 8596929
    [No Abstract]   [Full Text] [Related]  

  • 20. Releasing the Brakes on Cancer Immunotherapy.
    Littman DR
    Cell; 2015 Sep; 162(6):1186-90. PubMed ID: 26359975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.